Last week, Quantify’s Emilie Toresson Grip was invited to the first Swedish Steatotic Liver Disease (SLD) Think Tank, hosted by Karolinska Institutet.
24 hours packed with speed networking, group discussions, and insightful presentations.
The primary goals? […]
The use of Real-World Data (RWD) to support regulatory decisions is growing rapidly.
Several regulating agencies have in the past few years issued guidelines on the requirements on Real-World Evidence (RWE)-studies to be fit-for purpose for regulatory purposes.
Nordic data properties share […]
On September 17th, Quantify Finland participated in the Council for Choices in Health Care in Finland (COHERE Finland)10th anniversary seminar. The theme of the seminar was “Prioritization and the service portfolio in 2030.”
The day featured several thought-provoking presentations with highlights […]
PubMed®, Embase® and Google Scholar – what is the difference and when should I use each?
In the realm of HEOR, synthesizing evidence from diverse sources is crucial for informed decision-making.
Choosing the right database can significantly impact the quality and relevance […]
Sweden’s rich data infrastructure and progressive approach to digitalization present a unique opportunity for conducting ground-breaking research.
With a focus on transparency, accessibility, and comprehensive coverage, Swedish real-world data (RWD) is a cornerstone for impactful studies in HEOR.
Here are some key […]
Every year, Quantify Research supports Lif by providing EFPIA – European Federation of Pharmaceutical Industries and Associations with information needed for the W.A.I.T survey for Sweden, and performs […]
Next Wednesday 25th September our very own Ville Perälä will be speaking at the Medical Advisor Current Affairs day 2024, organized by Pharmaca Health Intelligence.
Ville’s talk “RWE in the work of a Medical Advisor […]
In an era where healthcare decisions are becoming increasingly complex, the ISPOR Value Flower offers a refreshing perspective on how we assess the true value of medical interventions.
What is it?
The Value Flower is a conceptual model that expands beyond traditional […]
Our capabilities have significantly expanded, allowing us to offer comprehensive support for your Finnish data and access needs.
As the leading provider of Nordic RWE and market access services, we’ve strengthened our Finnish presence to deliver:
▪ End-to-end RWE including patient-level data […]
We have an exciting and action-packed fall ahead of us, including:
– Growing our global service offering (including our newest office in Finland!)
– Annual September Kick-off
– Leadership training for senior staff
– A number of conferences, such as ISPOR EU, DIA RWE […]